Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
59 /100
HIGH RISK
Score updated Oct 13, 2026

SER — Serina Therapeutics, Inc. Dilution Risk Tracker

Track SER dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SER — Get alerts when the score changes →

As of October 13, 2026, Serina Therapeutics, Inc. (SER) has a DilutionWatch DilutionScore of 59/100, rated HIGH dilution risk. Serina Therapeutics, Inc. has a market capitalization of $50.80M, 25.40M shares outstanding, 25 institutional holders tracked. Stored dilution-related fields include 2.97M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
77
⚠️ Warrant Exposure
50
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 32%
🔁 Convertible Conversion model 40%
• Significant convertible debt: 18% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split model est. 30%
• 50-day avg $1.98 approaching $1 threshold
📜 Warrant Exercise model 15%
• Warrant overhang: 11.7% of shares outstanding
🔔 Track SER — Get forecast alerts →

Market Data

Market Cap$50.80M
Shares Outstanding25.40M
Float8.42M
Cash$23.02M
Debt$11.15M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore59/100DilutionWatch score record
Shares Outstanding25.40MVerified float table or market cache
Public Float8.42MVerified float table or market cache
Market Cap$50.80MMarket data cache
Cash Runway22.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants2.97MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 259.7% shares (2026Q1 vs prior)
25 institutional holders · 1.61M shares
#1 Sio Capital Management, LLC 1.00M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 318.3K shares
#3 Waverly Advisors, LLC 67.5K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest56.6K
Days to Cover1.0
% of Float0.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-25
xbrl XBRL CONVERTIBLE 2026-03-25
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual SER Dilution Snapshot

Serina Therapeutics, Inc. (SER) has a DilutionScore of 59/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SER's DilutionScore is currently 59/100 (High risk), with 4 score changes tracked over 89 days. The score improved from 53/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202659/100HIGH13 days
Sep 17 – Sep 30, 202653/100HIGH14 days
Aug 22 – Sep 16, 202654/100HIGH26 days
Aug 14 – Aug 21, 202649/100MEDIUM7 days
Jul 16 – Aug 13, 202650/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SER shares outstanding have increased 21.8% from 12.31M (Mar 2026) to 15.00M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 202615.00M8.42M▲ 21.79%
May 08, 202614.90M6.91M▲ 1.98%
Apr 24, 202612.31M6.78M▼ 0.93%
Apr 01, 202612.31M6.84M▲ 12.79%
Mar 27, 202612.31M6.06M▲ 15.47%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SER Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SER files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SER — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SER
SER FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.